+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Humulin"

From
From
From
From
From
From
Human Insulin Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Human Insulin Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 144 Pages
  • Global
From
From
From
From
From
From
From
From
US Diabetes Drug Market, Dosage, Price, Sales Insight 2021 - 2026 - Product Thumbnail Image

US Diabetes Drug Market, Dosage, Price, Sales Insight 2021 - 2026

  • Report
  • February 2021
  • 500 Pages
  • United States
From
From
From
Loading Indicator

Humulin is a brand of insulin used to treat endocrine and metabolic disorders. It is a recombinant human insulin, produced by genetically engineered bacteria, and is used to treat diabetes mellitus. It is available in several forms, including short-acting, intermediate-acting, and long-acting. Humulin is used to control blood sugar levels in people with type 1 and type 2 diabetes. It is also used to treat other endocrine and metabolic disorders, such as hyperglycemia, hypoglycemia, and polycystic ovary syndrome. Humulin is a widely used insulin, and is available in many countries around the world. It is available in both generic and branded forms, and is available in both injectable and oral forms. It is also available in combination with other medications, such as metformin and glipizide. The Humulin market is highly competitive, with many companies offering their own versions of the drug. Some of the major companies in the market include Eli Lilly, Novo Nordisk, Sanofi, Merck, and Pfizer. Show Less Read more